FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37856811000001100: Nerlynx 40mg tablets (Pierre Fabre Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
479441000001116 Nerlynx 40mg tablets (Pierre Fabre Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
479451000001118 Nerlynx 40mg tablets (Pierre Fabre Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Is a Neratinib 40mg tablets true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has specific active ingredient Neratinib maleate true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Neratinib true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Is a Nerlynx true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Nerlynx 40mg tablets (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Nerlynx 40mg tablets (Pierre Fabre Ltd) 180 tablet Has AMP True Nerlynx 40mg tablets (Pierre Fabre Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start